Keying Jing
Huijuan Zhao
Jun Cai1
Peiming Zheng
Rong Wang
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Henan University People's Hospital, Department of Clinical Laboratory, Henan Provincial People’s Hospital, Henan University, Zhengzhou, Henan, China
- 2Basic Medical College, Henan University of Science and Technology, Luoyang, Henan, China
- 3Henan Hospital of Integrated Chinese and Western Medicine, Zhengzhou, Henan, China
A Corrigendum on
The presence of autoantibodies is associated with improved overall survival in lung cancer patients
by Jing K, Zhao H, Cai J, Chen L, Zheng P, Ouyang L, Li G and Wang R (2023) Front. Oncol. 13:1234847. doi: 10.3389/fonc.2023.1234847
In the published article, there was an error in affiliations 1. Instead of 1Department of Clinical Laboratory, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Henan University, Zhengzhou, Henan, China, it should be 1Henan University People’s Hospital, Department of Clinical Laboratory, Henan Provincial People’s Hospital, Henan University, Zhengzhou, Henan, China.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: autoantibody, antinuclear antibody, extractable nuclear antigen, lung cancer, overall survival
Citation: Jing K, Zhao H, Cai J, Chen L, Zheng P, Ouyang L, Li G and Wang R (2023) Corrigendum: The presence of autoantibodies is associated with improved overall survival in lung cancer patients. Front. Oncol. 13:1353702. doi: 10.3389/fonc.2023.1353702
Received: 11 December 2023; Accepted: 12 December 2023;
Published: 19 December 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Jing, Zhao, Cai, Chen, Zheng, Ouyang, Li and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Gang Li, bGlnYW5nNjU1ODczNTlAMTYzLmNvbQ==; Rong Wang, d2FuZ3JvbmczNjYwMjAxMEAxNjMuY29t